Sopharma
- Company typePublic
- Founded1932
- HeadquartersSofia, Bulgaria
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Sopharma firmographics
Firmographics- Name
- Sopharma
- Legal name
- Sopharma AD (Софарма АД)
- Website
- https://sopharma.bg
- Company type
- Public
- Founded year
- 1932
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Sopharma industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Generic Hospital & Institutional Products (HLAIABAL), Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)
Keywords
Where Sopharma is headquartered
LocationHeadquarters
- HQ city
- Sofia
- HQ country
- Bulgaria
- HQ region
- Europe
Offices1 record
Markets served
Sopharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Sopharma generates revenue through manufacturing and selling generic pharmaceutical products. The company operates in the generic drug sector, selling products both domestically in Bulgaria and through export markets. Revenue for 2024 was 2,129,097 BGN '000 (consolidated).
- Contract Manufacturing: Sopharma offers contract manufacturing and development services to business partners through its dedicated B2B partnerships section, providing manufacturing capabilities and development services to other pharmaceutical companies.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels2 records
Sopharma product offering
Product offeringCore offering
Sopharma manufactures and distributes generic pharmaceutical products across multiple therapeutic areas for both the Bulgarian domestic market and international export markets. In addition to its own branded generic portfolio, the company offers business-to-business contract manufacturing and product development services and engages in pharmaceutical licensing deals with partner companies.
Product overview
Sopharma is a Bulgarian pharmaceutical company operating as a manufacturer in the generic drug sector. The company's portfolio includes generic pharmaceutical products distributed across therapeutic areas, complemented by business-to-business contract manufacturing and development services, as well as licensing deal partnerships. The product offering centers on generic pharmaceuticals with supporting manufacturing and licensing services for business customers.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Revenue growth of 41% year-on-year in Jan-May 2026
- +1 more outcomes
Companies that use Sopharma
Customer profileSegments3 records
Ideal customer profiles3 records
Sopharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Sopharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Business-to-Business PartnerscoreSopharma maintains dedicated business partnerships with pharmaceutical companies through contract manufacturing and development services. The company offers outsourcing manufacturing and development capabilities as well as licensing deals to other pharmaceutical businesses.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Sopharma competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Sopharma social profiles
Digital presenceSopharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sopharma leadership team
Management profileNumber of profiles
Profiles1 record
Sopharma funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sopharma M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sopharma
What does Sopharma do?
Sopharma manufactures and distributes generic pharmaceutical products across multiple therapeutic areas for both the Bulgarian domestic market and international export markets. In addition to its own branded generic portfolio, the company offers business-to-business contract manufacturing and product development services and engages in pharmaceutical licensing deals with partner companies.
Is Sopharma a public or private company?
Sopharma is a public company. It is classified as public and is currently operating.
When was Sopharma founded?
Sopharma was founded in 1932. It employs 1,001 to 5,000 people.
Where is Sopharma based?
Sopharma is headquartered in Sofia, Bulgaria, in the Europe region.
How does Sopharma make money?
Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are contract Manufacturing.
Does Sopharma have an API?
No public API is recorded for Sopharma.
What industry is Sopharma in?
Sopharma's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.